ArticleBlood cancer journal2016
Prevalence, incidence and survival of smoldering multiple myeloma in the United States.
Article in Blood cancer journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model.HemaSphere · 2026Article
- Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.Future oncology (London, England) · 2026Article
- Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.International journal of hematology · 2026Review
- Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012-2022.American journal of hematology · 2026Article
- Smoldering multiple myeloma in the United States: a population-based analysis.Blood advances · 2026Article
- Temporal trends in progression risk in smoldering myeloma: a systematic review.EClinicalMedicine · 2026Article
- Association Between Patient Demographics and Smoldering Multiple Myeloma Progression to Multiple Myeloma: A SEER-Medicare Data Analysis.Clinical lymphoma, myeloma & leukemia · 2025Article
- Determinants of 15-Year Progression-Free Survival in Multiple Myeloma; Real-World Data From a Single Institution.American journal of hematology · 2025Article
- Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.Annals of hematology · 2025Review
- Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma.Clinical lymphoma, myeloma & leukemia · 2025Article
- Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.Blood cancer journal · 2024Article
- Mode of progression in smoldering multiple myeloma: a study of 406 patients.Blood cancer journal · 2024Article
- The role of nutrition and gut microbiome in the progression of multiple myeloma and its precursor disease.Frontiers in oncology · 2024Review
- Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system.Annals of hematology · 2023Article
- Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients.Research square · 2023Article
- Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.Blood cancer journal · 2023Article
- The consultant's guide to smoldering multiple myeloma.Hematology. American Society of Hematology. Education Program · 2022Article
- How I approach smoldering multiple myeloma.Blood · 2022Review
- Pathogenesis and treatment of multiple myeloma.MedComm · 2022Review
- Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies.Hematology. American Society of Hematology. Education Program · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.